von Bartheld Martin B, Annema Jouke T
Department of Respiratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Department of Respiratory Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Respiratory Medicine, Academic Medical Center, Amsterdam, the Netherlands.
Gastrointest Endosc. 2015 Dec;82(6):1009-15. doi: 10.1016/j.gie.2015.03.1973. Epub 2015 Jun 5.
Endosonography is being implemented rapidly in pulmonary medicine for the diagnosis and staging of lung cancer, the assessment of sarcoidosis, and the assessment of mediastinal lesions. Although serious adverse events (SAEs) have been described, safety data outside cohort studies are scarce.
To assess the SAE and mortality rate of EUS-guided FNA (EUS-FNA) and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal and/or hilar analysis.
Nationwide, retrospective survey by using questionnaires.
All hospitals in the Netherlands.
All patients undergoing EUS-FNA and EBUS-TBNA for intrathoracic analysis in the period 1999 to 2011.
EUS-FNA and EBUS-TBNA.
Occurrence of fatal outcomes and SAEs. Detailed information was obtained for each reported case, and all cases were reviewed independently by 2 investigators, including identification of risk factors.
All 89 hospitals (100%) responded. An estimated 14,075 EUS-FNA and 2675 EBUS procedures were performed. Seven patients died after endosonography (5 EUS-FNA, 2 EBUS [mortality rate 0.04%]). All fatalities occurred in patients of poor performance status (American Society of Anesthesiologists Physical Status Classification System score of III/IV). Twenty-five SAEs were reported (22 EUS-FNA, 3 EBUS [SAE rate of 0.15%; EUS-FNA 0.16%, EBUS 0.11%]). SAEs were mostly (64%) of infectious origin. No specific risk factors for infectious adverse events could be identified.
Retrospective study, possible recall bias, overrepresentation of EUS-FNA cases.
Endosonography appears to be a safe technique for the analysis of mediastinal and/or hilar lesions. Poor performance status is a risk factor for fatal outcomes. Mediastinitis and/or mediastinal abscess formation is rare but is a potential and dangerous adverse event of endosonography.
内镜超声在肺部医学中迅速应用于肺癌的诊断与分期、结节病的评估以及纵隔病变的评估。尽管已有严重不良事件(SAEs)的相关描述,但队列研究之外的安全性数据却很匮乏。
评估超声内镜引导下细针穿刺活检(EUS-FNA)及支气管内超声引导下经支气管针吸活检(EBUS-TBNA)用于纵隔和/或肺门分析的严重不良事件及死亡率。
通过问卷调查进行全国性回顾性调查。
荷兰所有医院。
1999年至2011年期间接受EUS-FNA和EBUS-TBNA进行胸腔内分析的所有患者。
EUS-FNA和EBUS-TBNA。
致命结局和严重不良事件的发生情况。获取了每个报告病例的详细信息,所有病例由2名研究人员独立审查,包括识别危险因素。
所有89家医院(100%)均作出回应。估计共进行了14075例EUS-FNA和2675例EBUS操作。7例患者在内镜超声检查后死亡(5例EUS-FNA,2例EBUS [死亡率0.04%])。所有死亡均发生在身体状况较差的患者中(美国麻醉医师协会身体状况分类系统评分为III/IV)。报告了25例严重不良事件(22例EUS-FNA,3例EBUS [严重不良事件发生率0.15%;EUS-FNA为0.16%,EBUS为0.11%])。严重不良事件大多(64%)源于感染。未发现感染性不良事件的特定危险因素。
回顾性研究,可能存在回忆偏倚,EUS-FNA病例代表性过高。
内镜超声似乎是一种用于分析纵隔和/或肺门病变的安全技术。身体状况较差是致命结局的危险因素。纵隔炎和/或纵隔脓肿形成罕见,但却是内镜超声检查的一种潜在且危险的不良事件。